Healthcare provider profile · identity verified

Rosanne Beth Freeman Paz, MD

Internal Medicine · GAYLORD, MI · NPI 1205806593

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	348	79
Gabapentin	Gabapentin	266	41
Levothyroxine Sodium	Levothyroxine Sodium	261	53
Eliquis	Apixaban	250	39
Amlodipine Besylate	Amlodipine Besylate	181	33
Sertraline Hcl	Sertraline Hcl	173	28
Losartan Potassium	Losartan Potassium	165	39
Buspirone Hcl	Buspirone Hcl	145	27
Lisinopril	Lisinopril	144	29
Metoprolol Succinate	Metoprolol Succinate	144	36
Quetiapine Fumarate	Quetiapine Fumarate	143	22
Escitalopram Oxalate	Escitalopram Oxalate	140	26
Furosemide	Furosemide	115	42
Metformin Hcl	Metformin Hcl	113	24
Potassium Chloride	Potassium Chloride	113	34
Spironolactone	Spironolactone	110	20
Mirtazapine	Mirtazapine	109	21
Metoprolol Tartrate	Metoprolol Tartrate	104	24
Divalproex Sodium	Divalproex Sodium	100	16
Clopidogrel	Clopidogrel Bisulfate	95	22
Prednisone	Prednisone	94	32
Omeprazole	Omeprazole	90	32
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	84	16
Tramadol Hcl	Tramadol Hcl	84	24
Levetiracetam	Levetiracetam	81	12
Trazodone Hcl	Trazodone Hcl	80	21
Duloxetine Hcl	Duloxetine Hcl	77	19
Lorazepam	Lorazepam	75	32
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	74	18
Paroxetine Hcl	Paroxetine Hcl	73	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	71	30
Meloxicam	Meloxicam	71	18
Pregabalin	Pregabalin	71	suppressed
Bumetanide	Bumetanide	70	16
Tamsulosin Hcl	Tamsulosin Hcl	69	25
Pantoprazole Sodium	Pantoprazole Sodium	68	16
Ropinirole Hcl	Ropinirole Hcl	67	11
Finasteride	Finasteride	60	13
Oseltamivir Phosphate	Oseltamivir Phosphate	56	52
Carvedilol	Carvedilol	55	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	55	suppressed
Famotidine	Famotidine	52	12
Hydralazine Hcl	Hydralazine Hcl	49	suppressed
Metolazone	Metolazone	48	suppressed
Clonazepam	Clonazepam	47	suppressed
Donepezil Hcl	Donepezil Hcl	47	suppressed
Memantine Hcl	Memantine Hcl	47	suppressed
Novolog Flexpen	Insulin Aspart	46	15
Xarelto	Rivaroxaban	46	suppressed
Diclofenac Sodium	Diclofenac Sodium	45	suppressed
Aripiprazole	Aripiprazole	44	suppressed
Montelukast Sodium	Montelukast Sodium	44	11
Allopurinol	Allopurinol	43	suppressed
Jardiance	Empagliflozin	43	suppressed
Diazepam	Diazepam	41	suppressed
Alprazolam	Alprazolam	40	suppressed
Oxycodone Hcl	Oxycodone Hcl	40	13
Tizanidine Hcl	Tizanidine Hcl	39	11
Albuterol Sulfate	Albuterol Sulfate	38	22
Arexvy	Rsvpref3 Antigen/As01e/Pf	38	36
Oxybutynin Chloride Er	Oxybutynin Chloride	38	suppressed
Primidone	Primidone	38	suppressed
Baclofen	Baclofen	37	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	37	20
Glipizide	Glipizide	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	11
Risperidone	Risperidone	35	suppressed
Glimepiride	Glimepiride	34	suppressed
Olanzapine	Olanzapine	33	suppressed
Humalog Kwikpen U-100	Insulin Lispro	32	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	32	suppressed
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Methenamine Hippurate	Methenamine Hippurate	31	suppressed
Enulose	Lactulose	30	suppressed
Lamotrigine	Lamotrigine	30	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	19
Ceftriaxone	Ceftriaxone Sodium	26	12
Cholestyramine	Cholestyramine (With Sugar)	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Morphine Sulfate	Morphine Sulfate	26	19
Rosuvastatin Calcium	Rosuvastatin Calcium	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Lactulose	Lactulose	25	suppressed
Myrbetriq	Mirabegron	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	11
Cephalexin	Cephalexin	23	15
Midodrine Hcl	Midodrine Hcl	23	suppressed
Timolol Maleate	Timolol Maleate	23	suppressed
Latanoprost	Latanoprost	22	suppressed
Levofloxacin	Levofloxacin	22	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Morphine Sulfate Er	Morphine Sulfate	21	suppressed
Tradjenta	Linagliptin	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Formoterol Fumarate	Formoterol Fumarate	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	19	suppressed
Budesonide	Budesonide	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	18	suppressed
Ssd	Silver Sulfadiazine	18	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	17	suppressed
Nystatin	Nystatin	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Dalfampridine Er	Dalfampridine	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	15	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Clozapine	Clozapine	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Trintellix	Vortioxetine Hydrobromide	14	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	suppressed
Flecainide Acetate	Flecainide Acetate	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Roflumilast	Roflumilast	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Fingolimod	Fingolimod Hcl	12	suppressed
Invega Sustenna	Paliperidone Palmitate	12	suppressed
Lithium Carbonate	Lithium Carbonate	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Benztropine Mesylate	Benztropine Mesylate	11	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Simvastatin	Simvastatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error